Our research consultants have decades of experience in PRO measurement across diverse therapeutic conditions. We work closely with pharmaceutical, medical device and healthcare organizations on data measurement that aligns with regulatory recommendations in the U.S. and other geographies. Our scientifically led approach includes the analysis of any PRO measure, the burden of illness, and treatment effectiveness.Scientific Consulting
QualityMetric’s eCOA platform is a robust data collection, scoring and reporting portal. It can be custom tailored with the features and functionality needed to securely and accurately capture data from patients, clinicians or caregivers. Our scientists combine health outcomes expertise with our technology platform to identify the right measurement concepts for collecting the most insightful and patient-centric evidence.COA Solutions & Licensing Services
QualityMetric offers unique solutions for translation and cross-cultural adaptation. Guided by industry standards, we translate and validate all types of materials used in healthcare and the life sciences. We collaborate with hundreds of experienced local and international linguistic partners, overseeing every stage of the development process. Our goal is absolute conceptual equivalence, cultural appropriateness and content validity.Translation & Linguistic Validation
QualityMetric’s Short Form family of generic health surveys – in particular the SF-36v2® and SF-12v2® Health Surveys – includes the most widely used and cited PROs in the world. Designed for use across the product lifecycle, they are an efficient, scientifically valid way of evaluating safety and efficacy, real world evidence through product performance, and post authorization safety surveillance; and they support post-launch direct-to-consumer (DTC) marketing and disease management.
QualityMetric collaborates with the world’s largest life science and healthcare organizations to measure and better understand health outcomes. We are also committed to supporting global academic institutions by making our clinical outcome assessment (COA) solutions royalty-free for unfunded students and university researchers.
From health surveys to expert analysis and methodologies, QualityMetric delivers all-inclusive outcome measurement solutions for capturing, benchmarking, and interpreting actionable patient-reported health information. For licensing requests, scientific consulting services, or linguistic translation and validation, please complete the following contact form.
Select the organization that best describes your company:
Please answer the following questions and we will be in touch regarding your license
QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.
If you have started administering the survey, please email a copy of the survey being administered to [email protected]. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).
If you are applying for a student license, please email a copy of your student ID to [email protected].
QualityMetric (QM), a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO), has announced its partnership with the Amyloidosis Research Consortium (ARC) in supporting the licensing and use of the Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL), a patient-reported outcome (PRO) survey specific to ATTR amyloidosis.
Using PRO Measures in Amyloidosis Research Amyloidosis refers to a group of rare diseases caused by the buildup of misfolded proteins in various tissues and organs in the body, often leading to organ damage and impaired quality of life. 1Given the rareness of systemic amyloidosis, there can be limited opportunities to gather data on the […]Read More
QualityMetric, an IQVIA business (QM), has contracted with LunaPBC to build a patient-driven oncology instrument for measuring the impacts on physical functioning across many cancers.Read More
Join the QualityMetric science team for several exciting presentations at the 30th Annual ISOQOL Conference in Calgary, Alberta, Canada, from October 18th through the 21st. This year’s conference theme, Quality of Life, focuses on identifying and overcoming the barriers that limit the use of patient-reported outcomes (PROs) in everyday patient care. QualityMetric’s scientists are well-versed in this area of our work and aim to share best practices, tips and more in their presentations throughout ISOQOL 2023. We hope to see you at one of the following sessions!Read More
Integrating PROMs into Pediatric Clinical Practice & Research Healthcare for children has been improving drastically over the past century and beyond, and we’ve seen much lower rates of infectious diseases thanks to the advent of vaccines and modern medicine.1 As a result, this reduction in illness has led to better health-related quality of life (HRQoL) […]Read More
Importance of PRO Selection for Medical Device Regulation Navigating the regulatory process to build product label and marketing claims can be difficult, especially when it comes to selecting endpoints that generate the right type of evidence to support those claims. For this reason selecting the right patient-reported outcome (PRO) instrument is essential to whether for […]Read More
QualityMetric Scientist Presenting During ISPOR Boston 2023 Don’t miss the informative sessions with QM scientists during the upcoming conference hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) this May in Boston. A Time Trade-Off Study to Estimate Respiratory Syncytial Virus (RSV) Related Utility Values for Older Adults (OA) in the Unites […]Read More